Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Asco Her2'

Asco Her2 published presentations and documents on DocSlides.

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 32 Slides

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 0 Slides

Clinical Practice Guideline Update. American Soci...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

  • danika-pritchard
  • 0 Slides

ASCO-CAP Recommendations For HER2 Testing in Brea...

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

  • hadley
  • 50 Slides

Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

  • alexa-scheidler
  • 0 Slides

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

  • lily
  • 29 Slides

Senior Investigator, . Breast Cancer Research. Ten...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

  • test
  • 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

  • marina-yarberry
  • 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

  • norah
  • 38 Slides

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

  • carny
  • 14 Slides

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

  • arya
  • 28 Slides

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

  • ximena
  • 32 Slides

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA

DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA

  • conchita-marotz
  • 16 Slides

The ASCO 7000 ERIES Generator Paralleling Control...

Advances in the Immunotherapy of Solid Tumors

Advances in the Immunotherapy of Solid Tumors

  • myesha-ticknor
  • 26 Slides

Malignant Melanoma. (8 minutes). Antoni Ribas, M....

ASCO 2010:

ASCO 2010:

  • phoebe-click
  • 75 Slides

. Highlights from the Annual Clinical Meeting. G...

Genetic plasma cell signatures in high-risk smoldering myel

Genetic plasma cell signatures in high-risk smoldering myel

  • trish-goza
  • 24 Slides

Presented By Sham Mailankody at 2016 ASCO Annual ...

Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian Function

Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian Function

  • tatiana-dople
  • 22 Slides

Presented By Olivia Pagani at 2014 ASCO Annual Me...

Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final

Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final

  • thegagn
  • 33 Slides

Presented By Lorenz Trumper at 2016 ASCO Annual Me...

CONKO-007: Chemoradiotherapy vs

CONKO-007: Chemoradiotherapy vs

  • davies
  • 12 Slides

Chemotherapy Alone for Unresectable . Locally Adva...

Meeting summary ASCO GU 2020,

Meeting summary ASCO GU 2020,

  • patricia
  • 27 Slides

San Francisco. , USA. Assoc. . Prof. . Shilpa Gupt...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

  • alida-meadow
  • 59 Slides

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

William J.

William J.

  • tawny-fly
  • 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

  • luanne-stotts
  • 0 Slides

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

  • debby-jeon
  • 0 Slides

Monica Brown, MPH, PhD. . California Cancer Regi...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

  • liane-varnes
  • 0 Slides

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

  • coursion
  • 1 Slides

across the breast cancer therapy spectrum. Phase I...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

  • katrgolden
  • 50 Slides

Contents PageIntended Use 4Summary and Explanation...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

  • Kingslayer
  • 19 Slides

A. University of Tennessee Medical Center – Knox...

Nanotek & Expo 2014

Nanotek & Expo 2014

  • DaintyLittlePrincess
  • 16 Slides

Biodegradable . nanobrushes. for drug delivery. ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

  • emery
  • 8 Slides

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Central Asian Journal of

Central Asian Journal of

  • cady
  • 10 Slides

15 Medical and Pharmaceutical Sciences Innovation ...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

  • elizabeth
  • 49 Slides

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

  • wang
  • 55 Slides

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

  • gelbero
  • 35 Slides

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

CA BREAST D r S ana

CA BREAST D r S ana

  • oconnor
  • 68 Slides

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

  • unita
  • 31 Slides

Dr. Vicente Marco. Department of Pathology. Hospit...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

  • caroline
  • 43 Slides

Lisa A. Carey MD, . ScM. University of North Carol...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

  • unita
  • 59 Slides

Percent with Patients. Number of Patients (Median)...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

  • delcy
  • 117 Slides

Trastuzumab-emtansine. : A . very. . nice. . poi...

Copyright © 2024 DocSlides. All Rights Reserved